Dermatology 236(6):571592 Bibeau K, Pandya AG, Ezzedine K et al (2022) Vitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
while unlikely to significantly affect interictal GSH levels given the short half-lives of these medications, we cannot completely rule out residual pharmacological effects
We designed a peptide inhibitor prototype, named p53 TAD PEP, comprising 16 amino acids corresponding to residues 4257 of the p53 TAD sequence (Figure
This route is preferred when the goal is systemic peptide exposure rather than topical mucosal contact
Research has examined these peptides for applications including muscle wasting conditions, age-related decline in growth hormone, and recovery from injury